- Headquarters
- Boston, United States · North America
- Value chain
- Medicines & vaccines(Products); also Research & IP
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1989
- Ownership
- Listed
- Listing
- Nasdaq:VRTX on Google Finance
- Website
- vrtx.com
- Relevance
- Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Boston, United StatesIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #18 of 50
Co-developed Casgevy, the first approved CRISPR gene-editing therapy (with CRISPR Therapeutics), and is advancing stem-cell-derived islet cell therapy.
Relevance: Co-developed first CRISPR therapy